Brief: Iteos Reports Third Quarter 2023 Financial Results And Provides Business Updates
07/11/2023 12:06
Nov 7 (Reuters) - Iteos Therapeutics Inc ITOS.O :
* ITEOS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATES
* SAYS CASH BALANCE AND INVESTMENT BALANCE OF $644.9 MILLION
AS OF
SEPTEMBER 30, 2023 EXPECTED TO PROVIDE RUNWAY THROUGH 2026
* QTRLY NET LOSS OF $0.90 PER BASIC AND DILUTED SHARE
* Q3 EARNINGS PER SHARE VIEW $-1.20 -- LSEG IBES DATA
Source text for Eikon: ID:nGNXbHQ6pm
Further company coverage: ITOS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on iTeos Therapeutics
See all newsIteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview
Brief: Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right
U.S. STOCKS ON THE MOVE-Nvidia, Salesforce, Kestrel Group
U.S. STOCKS ON THE MOVE-Dick's Sporting Goods, Sonic Automotive